Read more at The Wall Street Journal.
The Price War in Weight-Loss Drugs Is Here
Date: |
-
CNBC - Business
'Stop ripping us off': Senate grills Novo Nordisk CEO on weight loss drug pricing
Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.16 minutes ago -
NBC News - Top stories
Ozempic CEO agrees to discuss lower prices for blockbuster weight loss drugs
Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO testified on Capitol Hill Tuesday.1 hour ago -
CNBC - Business
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an antitrust suit against Epic Systems.2 hours ago -
The Guardian - World
The Guardian view on Israel and Hezbollah: the war is already here | Editorial
Dangers to the Middle East continue to grow with strikes on Lebanon. De-escalation through escalation is not a strategy, just wishful thinking. For almost a year now, the danger of a wider ...2 hours ago - Israel -
MarketWatch - Business
Novo Nordisk CEO spars with lawmakers over Ozempic, Wegovy prices
The CEO of Novo Nordisk faced pointed questions about the cost of Ozempic and Wegovy on Capitol Hill Tuesday, as lawmakers pressed the Danish pharmaceutical giant to cut the prices of its ...3 hours ago -
The Hill - Politics
Watch live: Senate HELP committee grills Novo Nordisk on weight loss drug pricing
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, is set to grill Novo Nordisk CEO Lars Jorgenson Tuesday morning over prices on the ...6 hours ago -
CBS News - Top stories
Ozempic maker to testify before Senate committee on weight loss drug prices
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on Tuesday.7 hours ago -
MarketWatch - Business
If there’s a nuclear renaissance, here are the stocks to watch, says UBS
There’s genuine excitement in the air around nuclear power. Here are companies that can benefit.7 hours ago -
The Hill - Politics
Novo CEO to blame drug middlemen
Presented by Prevent Cancer Foundation — The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss drugs Ozempic and Wegovy. ...22 hours ago -
CBS News - Top stories
Gold's price surges past $2,600. Here's why you should invest now.
The price of gold is continuing its upward trajectory — and there are a few reasons to consider buying in now.Yesterday -
CBS News - Top stories
Fentanyl fuels worst drug crisis in U.S. history
60 Minutes correspondent Bill Whitaker breaks down how fentanyl has been spreading through the U.S., quickly becoming America's worst drug crisis. Whitaker visited the border with Mexico to see how ...Yesterday -
Yahoo News - World
Chinese EV maker Xpeng adds Qatar to export list amid price war at home
Yesterday -
BBC News - Top stories
Tesco's Aldi price match products are not always like-for-like, BBC finds
Some Tesco price-matches have lower proportions of the main ingredient than Aldi's, BBC Panorama finds.Yesterday -
Financial Times - World
Novo Nordisk faces US Senate grilling over price of weight loss drugs
Senator Bernie Sanders accuses Ozempic and Wegovy maker of ‘ripping off’ AmericansYesterday -
Inc. - Business
Drought Conditions Threaten Brazilian Coffee Pipeline, Prices
Brazil--the world's largest coffee producer--is grappling with the nation's worst drought in over seven decades.Yesterday - Brazil -
NBC News - Top stories
Here's the biggest news you missed this weekend
Harris builds momentum over Trump, NBC News poll finds. Israel and Hezbollah trade heavy fire. Diddy shielded by fame. How one server makes ends meet in Miami.Yesterday -
The New York Times - Sports
New College Football Is Here
Saturday’s USC-Michigan thriller was a three-hour advertisement for the new era, a columnist for The Athletic writes.2 days ago - College Football -
The New York Times - Sports
The W.N.B.A. Playoffs Have Arrived. Here’s Everything to Know.
The most-hyped regular season since the league’s inception delivered excitement from start to finish, but the real drama is just getting started.2 days ago -
Financial Times - World
The path to global carbon pricing
To tackle climate change, the polluter pays principle needs to spread further and wider2 days ago -
CNBC - Business
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.3 days ago -
Financial Times - Business
Nuclear fuel prices surge as west rues shortage of conversion facilities
Bottlenecks have built up in uranium supply chain since Russian invasion of Ukraine3 days ago -
The New York Times - Health
Drug Overdose Deaths Are Dropping. The Reasons Are Not Perfectly Clear.
The decrease across the country is a major breakthrough in efforts to reverse the effects of fentanyl. Researchers and health officials say there is no easy explanation for the trend.3 days ago -
NBC News - Top stories
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.3 days ago -
ABC News - Health
An appeals court has revived a challenge to President Biden's Medicare drug price reduction program
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription drugs has been revived by a federal appeals court3 days ago - Joe Biden -
The Hill - Politics
FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while “artificially” ...4 days ago -
MarketWatch - Business
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.4 days ago -
The New York Times - Health
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.4 days ago -
The New York Times - Business
What’s Next for Rate Cuts? The Fed Is Watching Jobs and Prices.
A Federal Reserve official predicted quarter point rate cuts if data looked ‘fine’. But he also set out a scenario for a pause — or faster reductions.4 days ago - Federal Reserve -
Financial Times - Business
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Complaint alleges pharmacy benefit managers owned by CVS, Cigna and UnitedHealth are keeping prices high4 days ago -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.4 days ago -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.4 days ago -
Yahoo News - World
Drought affecting Brazil’s coffee crops may push prices higher
4 days ago - Brazil
More from The Wall Street Journal
-
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.4 days ago -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.4 days ago -
The Wall Street Journal - Business
Salesforce Taps Nvidia to Develop AI-Powered Avatars
The San Francisco companies said the collaboration will develop autonomous-agent and interactive-avatar experiences.6 days ago -
The Wall Street Journal - Business
Boeing Machinist Strike Adds Cash Crunch to New CEO's Rescue Mission
Ratings firms are warning that a prolonged work stoppage could sink the jet maker’s debt into junk status.September 15 -
The Wall Street Journal - Business
Battery Maker Northvolt to Cut Jobs Amid Cooling EV Market
Northvolt will cut jobs as part of a broad cost-saving plan to streamline the business following a period of aggressive expansion and as the global electric-vehicle market cools.September 9